s9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both pi3k-akt-mtor signaling and microtubule cytoskeletons9,一种抗癌剂,对其anti-proliferative活动通过干扰pi3k-akt-mtor信号和微管细胞骨架.pdfVIP

下载本文档

0
0
约7.47万字
约 11页
2017-09-09 发布于上海
举报
版权申诉

s9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both pi3k-akt-mtor signaling and microtubule cytoskeletons9,一种抗癌剂,对其anti-proliferative活动通过干扰pi3k-akt-mtor信号和微管细胞骨架.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

s9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both pi3k-akt-mtor signaling and microtubule cytoskeletons9,一种抗癌剂,对其anti-proliferative活动通过干扰pi3k-akt-mtor信号和微管细胞骨架

S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton 1. 1. 2 2 3 3 2 Chao Zhang , Na Yang , Chun-hao Yang , Hua-sheng Ding , Cheng Luo , Yu Zhang , Mao-jiang Wu , 1 3,4 3,4 1 1 Xiong-wen Zhang , Xu Shen , Hua-liang Jiang , Ling-hua Meng *, Jian Ding * 1 Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, 2 Division of Organic Synthesis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, 3 Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, 4 School of Pharmacy, East China University of Science and Technology, Shanghai, China Abstract Background: Deregulation of the phosphatidylinositol 3-kinases (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway plays a central role in tumor formation and progression, providing validated targets for cancer therapy. S9, a hybrid of a-methylene-c-lactone and 2-phenyl indole compound, possessed potent activity against this pathway. Methodology/Principal Findings: Effects of S9 on PI3K-Akt-mTOR pathway were determined by Western blot, immunofluorescence staining and in vitro kinas assay. The interactions between tubulin and S9 were investigated by polymerization assay, CD, and SPR assay. The potential binding modes between S9 and PI3K, mTOR or tubulin were analyz